Geldanamycin as a Potential Anti-Cancer Agent: Its Molecular Target and Biochemical Activity
- 1 November 1999
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 17 (4), 361-373
- https://doi.org/10.1023/a:1006382320697
Abstract
Heat shock protein 90 is one of the most abundantcellularproteins. Although its functions are still being characterized,itappears to serve as a chaperone for a growing list of cellsignaling proteins, including many tyrosine and serine/threoninekinases, involved in proliferation and/or survival. Thebenzoquinone ansamycin geldanamycin has been shown to bind toHsp90and to specifically inhibit this chaperone's function, resultinginclient protein destabilization. Its ability to simultaneouslystimulate depletion of multiple oncogenic proteins suggests thatgeldanamycin, or other molecules capable of targeting Hsp90 incancer cells, may be of clinical benefit.Keywords
This publication has 114 references indexed in Scilit:
- Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinasesCell Stress and Chaperones, 1999
- Geldanamycin-Induced Destabilization of Raf-1 Involves the ProteasomeBiochemical and Biophysical Research Communications, 1997
- Cdc37 is a molecular chaperone with specific functions in signal transduction.Genes & Development, 1997
- Physical Interaction of Mammalian CDC37 with CDK4Published by Elsevier ,1996
- Expression and Roles of Heat Shock Proteins in Human Breast CancerJapanese Journal of Cancer Research, 1996
- Herbimycin A Induces the 20 S Proteasome- and Ubiquitin-dependent Degradation of Receptor Tyrosine KinasesPublished by Elsevier ,1995
- The Glucose-Regulated Proteins (GRP78 and GRP94): Functions, Gene Regulation, and ApplicationsCritical Reviews™ in Eukaryotic Gene Expression, 1994
- Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activationBiochemistry, 1992
- Clinical and biological significance of HSP89 alpha in human breast cancerInternational Journal of Cancer, 1992
- The specific interaction of the Rous sarcoma virus transforming protein, pp60src, with two cellular proteinsCell, 1981